Status:
COMPLETED
Impact of COVID-19 on Marshallese Communities in the U.S.
Lead Sponsor:
University of Arkansas
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Marshallese adults in the U.S. will complete an online or telephone survey. This survey will collect data describing the impact of COVID-19 on Marshallese communities. Data collected will help describ...
Detailed Description
Background and Rationale While there is much we do not know about the differential effects of COVID-19, early data shows that minority communities are disproportionally effected by the virus. There a...
Eligibility Criteria
Inclusion
- Self-reported Marshallese
- 18 years of age or older
- Live in the Continental U.S. or Hawaii
Exclusion
- \- Does not meet inclusion criteria
Key Trial Info
Start Date :
July 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04474496
Start Date
July 27 2020
End Date
November 30 2020
Last Update
April 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences Northwest
Fayetteville, Arkansas, United States, 72703